PARP1 and Ewing sarcoma: High expression of TMPRSS2:Erg in prostate cancers or EWS-Fli1 in Ewing sarcoma causes DNA damages that are potentiated by PARP-1 inhibition and are followed by strong inhibition of cancer progression.